title: Synthesis and evaluation of chitosan-graft-poly (2-hydroxyethyl methacrylate-co-itaconic acid) as a drug carrier for controlled release of tramadol hydrochloride.
abstract: Chitosan-graft-poly (2-hydroxyethyl methacrylate-co-itaconic acid) has been synthesized for different feed ratios of 2-hydroxyethyl methacrylate and itaconic acid and characterized by FT-IR, thermogravimetry and swelling in simulated biological fluids (SBF) and evaluated as a drug carrier with model drug, tramadol hydrochloride (TRM). Grafting decreased the thermal stability of chitosan. FT-IR spectra of tablet did not reveal any molecular level (i.e. at <10 nm scale) drug-polymer interaction. But differential scanning calorimetric studies indicated a probable drug-polymer interaction at a scale >100 nm level. The observed Korsmeyer-Peppas's power law exponents (0.19-1.21) for the in vitro release profiles of TRM in SBF and other drugs such as 5-fluorouracil (FU), paracetamol (PCM) and vanlafaxine hydrochloride (VNF) with the copolymer carriers revealed an anomalous drug release mechanism. The decreased release rates for the grafted chitosan and the enhanced release rate for the grafts with increasing itaconic acid content in the feed were more likely attributed to the enhanced drug-matrix interaction and polymer-SBF interactions, respectively. The different release profiles of FU, PCM, TRM and VNF with the copolymer matrix are attributed to the different chemical structures of drugs. The above features suggest the graft copolymer's candidature for use as a promising oral drug delivery system.
authors: Department of Biotechnology, Bannari Amman Institute of Technology, Sathyamangalam, Erode 638 401, Tamil Nadu, India.
authors: Kaliappa Gounder
authors: KG
authors: Subramanian
authors: Vediappan
authors: V
authors: Vijayakumar
keywords: Fourier transform-infrared; Graft copolymer; In vitro drug release; Simulated biological fluids; Thermal stability; Tramadol hydrochloride
references: Adv Drug Deliv Rev. 2010 Jan 31;62(1):83-99
references: 19799949
references: Eur J Pharm Biopharm. 2000 Jul;50(1):27-46
references: 10840191
references: Chem Rev. 2004 Dec;104(12):6017-84
references: 15584695
references: Chem Rev. 2001 Nov;101(11):3245-73
references: 11840986
references: AAPS PharmSciTech. 2003;4(3):E31
references: 14621963
references: Drug Test Anal. 2009 May;1(5):240-4
references: 20355202
references: J Biomed Mater Res A. 2011 Jan;96(1):116-24
references: 21105159
references: Eur J Pharm Biopharm. 2001 Sep;52(2):231-5
references: 11522491
references: Int J Pharm. 2003 Jan 16;250(2):431-40
references: 12527169
references: Int J Pharm. 2000 Jan 25;194(2):169-80
references: 10692641